Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
  • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
  • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
  • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
  • C07D213/81—Amides; Imides
  • C07D213/82—Amides; Imides in position 3
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
  • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
  • A01N43/24—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
  • A01N43/32—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms six-membered rings
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
  • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
  • A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
  • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
  • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
  • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
  • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
  • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
  • A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
  • A01N43/76—1,3-Oxazoles; Hydrogenated 1,3-oxazoles
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
  • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
  • A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
  • A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
  • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/04—Antibacterial agents
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
  • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
  • C07C211/57—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton
  • C07C211/61—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton with at least one of the condensed ring systems formed by three or more rings
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
  • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
  • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
  • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
  • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
  • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
  • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
  • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
  • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
  • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
  • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
  • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
  • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
  • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
  • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
  • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
  • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
  • C07D327/06—Six-membered rings
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
  • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
  • C07D487/08—Bridged systems
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
  • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
  • C07D493/08—Bridged systems
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
  • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
  • C07D495/08—Bridged systems
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C2603/00—Systems containing at least three condensed rings
  • C07C2603/56—Ring systems containing bridged rings
  • C07C2603/58—Ring systems containing bridged rings containing three rings
  • C07C2603/60—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
  • C07C2603/66—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing five-membered rings

Definitions

• the present invention relates to novel tricyclic amine derivatives which have microbiocidal activity, in particular fungicidal activity.
• the invention also relates to the preparation of these compounds, to novel intermediates used in the preparation of these compounds, to agrochemical compositions which comprise at least one of the novel compounds as active ingredient, to the preparation of the compositions mentioned and to the use of the active ingredients or compositions in agriculture or horticulture for controlling or preventing infestation of plants by phytopathogenic microorganisms, preferably fungi.
• the present invention provides a compound of formula (I):
• Het is a 5- or 6-membered heterocyclic ring containing one to three heteroatoms, each independently selected from oxygen, nitrogen and sulphur, provided that the ring is not 1,2,3-triazole, the ring being substituted by groups R 8 , R 9 and R 10 ;
• X is a single or double bond;
• Y is O, S, N(R 11 ) or (CR 12 R 13 )(CR 14 R 15 ) m (CR 16 R 17 ) n ;
• m is 0 or 1;
• n is 0 or 1;
• R 1 is hydrogen, C 1-4 alkyl, C 1-4 haloalkyl, C 1-4 alkoxy, C 1-4 haloalkoxy, CH 2 C ⁇ CR 18 , CH 2 CR 19 ⁇ CHR 20 , CH ⁇ C ⁇ CH 2 or COR 21 ;
• R 2 and R 3 are each, independently, hydrogen, halogen, C 1-4 alkyl, C 1-4 alkoxy or C
• Halogen is fluoro, chloro, bromo or iodo; preferably fluoro, chloro or bromo.
• Each alkyl moiety is a straight or branched chain and is, for example, methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, iso-propyl, sec-butyl, iso-butyl, tert-butyl, neo-pentyl, n-heptyl, 1,3-dimethylbutyl, 1,3-dimethylpentyl, 1-methyl-3-ethyl-butyl or 1,3,3-trimethylbutyl.
• each alkylene moiety is a straight or branched chain.
• Haloalkyl moieties are alkyl moieties which are substituted by one or more of the same or different halogen atoms and are, for example, CF 3 , CF 2 Cl, CHF 2 , CH 2 F, CCl 3 , CF 3 CH 2 , CHF 2 CH 2 , CH 2 FCH 2 , CH 3 CHF or CH 3 CF 2 .
• Alkenyl and alkynyl moieties can be in the form of straight or branched chains.
• Each alkenyl moiety may be of either the (E)- or (Z)-configuration.
• a 3-5 membered carbocyclic ring includes a spiro-three or five membered ring.
• Aryl includes phenyl, naphthyl, anthracyl, fluorenyl and indanyl but is preferably phenyl.
• Alkylidene moieties may be in the form of straight or branched chains.
• Alkylidene includes methylidene [CH 2 ⁇ ], ethylidene [CH 3 C(H) ⁇ ], n-propylidene, i-propylidene [(CH 3 ) 2 C ⁇ ], n-butylidene, i-butylidene, 2-butylidene, n-pentylidene, i-pentylidene, neo-pentylidene, 2-pentylidene, n-hexylidene, 2-hexylidene, 3-hexylidene, i-hexylidene and neo-hexylidene.
• Cycloalkyl includes cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl.
• Cycloalkenyl includes cyclobutenyl, cyclopentenyl, cyclohexenyl and cycloheptenyl.
• Cycloalkylidene includes cyclopropylidene [c(C 3 H 4 ) ⁇ ], cyclobutylidene, cyclopentylidene and cyclohexylidene.
• R 11 is hydrogen, C 1-4 alkyl, benzyl (in which the phenyl group is optionally substituted with up to three substituents, each independently selected from halogen, C 1-4 alkyl, C 1-4 haloalkyl and C 1-4 alkoxy), formyl, C(O)C 1-4 alkyl or C 1-4 alkoxy(C 1-4 )alkylene.
• R 12 , R 13 , R 14 , R 15 , R 16 and R 17 are each, independently, hydrogen, C 1-4 alkyl or C 1-4 alkoxy.
• Het is preferably pyrrolyl, pyrazolyl, thiazolyl, oxazolyl, pyridinyl, pyrimidyl, pyridazinyl, 2,3-dihydro-[1,4]oxathiine-6-yl, oxazinyl, thiazinyl or triazinyl.
• Het is more preferably pyrrolyl, pyrazolyl, thiazolyl, oxazolyl, pyridinyl or 2,3-dihydro-[1,4]oxathiine-yl.
• Het is even more preferably pyrrolyl, pyrazolyl, thiazolyl or pyridinyl.
• Het is most preferably pyrrolyl or pyrazolyl.
• X is a single bond.
• Y is O, S, N(R 11 ), CH 2 , CH 2 CH 2 , CH 2 CH 2 CH 2 , C(CH 3 ) 2 , CH(CH 3 ), CH(C 2 H 5 ), C(CH 3 )(C 2 H 5 ), CH(OCH 3 ) or C(OCH 3 ) 2 ; more preferably N(R 11 ), O, S, CH 2 , CH 2 CH 2 , CH 2 CH 2 CH 2 , C(CH 3 ) 2 , CH(CH 3 ) or CH(C 2 H 5 ); even more preferably N(R 11 ), O, S, CH 2 or CH 2 CH 2 , and still more preferably O, CH 2 or N(R 11 ).
• Y is O, N(R 11 ) or (CR 12 R 13 )(CR 14 R 15 ) m (CR 16 R 17 ) n .
• Y is O or (CR 12 R 13 )(CR 14 R 15 ) m (CR 16 R 17 ) n .
• Y is (CR 12 R 13 )(CR 14 R 15 ) m (CR 16 R 17 ) n .
• Y is (CR 12 R 13 ).
• n 0.
• m is 0.
• R 1 is hydrogen, CH 2 C ⁇ CR 18 , CH ⁇ C ⁇ CH 2 or COR 21 .
• R 1 is hydrogen, CH 2 C ⁇ CH, CH ⁇ C ⁇ CH 2 , C(O)H or C(O)CH 3 .
• R 1 is hydrogen, CH 2 C ⁇ CH, CH ⁇ C ⁇ CH 2 or C(O)CH 3 .
• R 1 is hydrogen, CH 2 C ⁇ CH or CH ⁇ C ⁇ CH 2 .
• R 1 is hydrogen
• R 2 is hydrogen, halogen or C 1-4 alkyl.
• R 2 is hydrogen or halogen.
• R 2 is hydrogen
• R 3 is hydrogen or methyl.
• R 3 is hydrogen.
• R 4 is hydrogen, C 1-4 alkyl, halogen, C 1-4 haloalkyl, C 1-4 alkoxy, C(O)CH 3 or C(O)OCH 3 .
• R 4 is hydrogen, C 1-2 alkyl, halogen, CF 3 , methoxy, C(O)CH 3 or C(O)OCH 3 .
• R 4 is hydrogen, methyl, chlorine, CF 3 or methoxy.
• R 4 is hydrogen or methyl.
• R 5 is hydrogen, C 1-4 alkyl, halogen, C 1-4 haloalkyl, C 1-4 alkoxy, C(O)CH 3 or C(O)OCH 3 .
• R 5 is hydrogen, C 1-2 alkyl, chlorine, CF 3 , methoxy, C(O)CH 3 or C(O)OCH 3 .
• R 5 is hydrogen or methyl.
• R 6 is hydrogen, C 1-4 alkyl, C 1-4 alkoxy or C(O)CH 3 .
• R 6 is hydrogen, methyl, methoxy or C(O)CH 3 .
• R 6 is hydrogen or methyl.
• R 7 is hydrogen, C 1-4 alkyl, C 1-4 alkoxy or C(O)CH 3 .
• R 7 is hydrogen, methyl, methoxy or C(O)CH 3 .
• R 7 is hydrogen or methyl.
• R 8 is hydrogen, halogen, C 1-4 alkyl, C 1-4 haloalkyl or methoxymethylene.
• R 8 is hydrogen, chloro, fluoro, bromo, C 1-2 alkyl, CF 3 , CF 2 Cl, CHF 2 , CH 2 F or methoxymethylene.
• R 8 is hydrogen, chloro, fluoro, C 1-2 alkyl, CF 3 , CF 2 Cl, CHF 2 , CH 2 F or methoxymethylene.
• R 8 is hydrogen, chloro, fluoro, methyl, CF 3 , CHF 2 or CH 2 F.
• R 9 is hydrogen, halogen, C 1-4 alkyl or C 1-4 haloalkyl or methoxymethylene.
• R 9 is hydrogen, chloro, fluoro, bromo, C 1-2 alkyl, CF 3 , CF 2 Cl, CHF 2 , CH 2 F or methoxymethylene.
• R 9 is hydrogen, chloro, fluoro, C 1-2 alkyl, CF 3 , CF 2 Cl, CHF 2 , CH 2 F or methoxymethylene.
• R 9 is hydrogen, chloro, fluoro, methyl, CF 3 , CHF 2 or CH 2 F.
• R 10 is hydrogen, halogen, C 1-4 alkyl, C 1-4 haloalkyl or methoxymethylene.
• R 10 is hydrogen, chloro, fluoro, bromo, C 1-2 alkyl, CF 3 , CF 2 Cl, CHF 2 , CH 2 F or methoxymethylene.
• R 10 is hydrogen, chloro, fluoro, C 1-2 alkyl, CF 3 , CF 2 Cl, CHF 2 , CH 2 F or methoxymethylene.
• R 10 is hydrogen, chloro, fluoro, methyl, CF 3 , CHF 2 or CH 2 F.
• R 11 is hydrogen, C 1-4 alkyl, benzyl, formyl, C(O)CH 3 or C(O)OC(CH 3 ) 3 ; more preferably hydrogen or C 1-2 alkyl.
• R 11 is C 1-4 alkyl, formyl, C(O)CH 3 or C(O)OC 1-6 alkyl (optionally substituted by halogen, CN or C 1-4 alkoxy).
• R 11 is C(O)OC 1-4 alkyl.
• R 12 , R 13 , R 14 , R 15 , R 16 and R 17 are each, independently, hydrogen, C 1-2 alkyl or methoxy.
• R 12 and R 13 are each, independently, hydrogen, halogen, C 1-5 alkyl, C 1-3 alkoxy, CH 2 OH, CH(O), C 3-6 cycloalkyl, CH 2 O—C( ⁇ O)CH 3 , CH 2 —C 3-6 cycloalkyl or benzyl; or R 12 and R 13 together with the carbon atom to which they are attached form the group C ⁇ O or a 3-5 membered carbocyclic ring; or R 12 and R 13 together form C 1-5 alkylidene or C 3-6 cycloalkylidene.
• R 12 and R 13 are, independently, H, CH 3 , C 2 H 5 , n-C 3 H 7 , i-C 3 H 7 , n-C 4 H 9 , sec-C 4 H 9 , i-C 4 H 9 , CH(C 2 H 5 ) 2 , CH 2 -cyclopropyl or cyclopentyl; or R 12 and R 13 together with the carbon atom to which they are attached form a 3-membered or 5-membered carbocyclic ring.
• R 14 is H or CH 3 .
• R 15 is H or CH 3 .
• R 16 is H or CH 3 .
• R 17 is H or CH 3 .
• R 18 is hydrogen, chloro, bromo, methyl or methoxy.
• R 18 is hydrogen, chloro or methyl.
• R 18 is hydrogen.
• R 19 is hydrogen, chloro, bromo, methyl or methoxy.
• R 19 is hydrogen, chloro or methyl.
• R 19 is hydrogen.
• R 20 is hydrogen, chloro, bromo, methyl or methoxy.
• R 20 is hydrogen, chloro or methyl.
• R 20 is hydrogen.
• R 21 is hydrogen, methyl, OC(CH 3 ) 3 or CH 3 OCH 2 .
• the present invention provides a compound of formula (C) where Y is O or S; and R 4 , R 5 , R 6 and R 7 are each C(O)OCH 3 ; or Y is N(R 11 ) or (CR 12 R 13 )(CR 14 R 15 ) m (CR 16 R 17 ) n ; R 4 , R 5 , R 6 , R 7 , R 14 , R 15 , R 16 , R 17 , m and n are each as defined above for a compound of formula (I); R 11 is benzyl (in which the phenyl group is optionally substituted with up to three substituents, each independently selected from halogen, C 1-4 alkyl, C 1-4 haloalkyl and C 1-4 alkoxy); and R 12 and R 13 together with the carbon atom to which they are attached form a 3-5 membered carbocyclic ring (optionally substituted by up to three methyl groups and containing 1 or 2 heteroatoms each independently
• the present invention provides a compound of formula (D) where Y is O or S; and R 4 , R 5 , R 6 and R 7 are each C(O)OCH 3 ; or Y is N(R 11 ) or (CR 12 R 13 )(CR 14 R 15 ) m (CR 16 R 17 ) n ; R 4 , R 5 , R 6 , R 7 , R 14 , R 15 , R 16 , R 17 , m and n are each as defined above for a compound of formula (I); R 11 is benzyl (in which the phenyl group is optionally substituted with up to three substituents, each independently selected from halogen, C 1-4 alkyl, C 1-4 haloalkyl and C 1-4 alkoxy); and R 12 and R 13 together with the carbon atom to which they are attached form a 3-5 membered carbocyclic ring (optionally substituted by up to three methyl groups and containing 1 or 2 heteroatoms each independently
• the compounds of formula (I), (C) and (D) may exist as different geometric or optical isomers or in different tautomeric forms.
• This invention covers, for each formula, all such isomers and tautomers and mixtures thereof in all proportions as well as isotopic forms such as deuterated compounds.
• Table 1 provides 94 compounds of formula (C) wherein Y, R 4 , R 5 , R 6 and R 7 are as defined in Table 1.
• Table 2 provides 111 compounds of formula (D) wherein Y, R 4 , R 5 , R 6 and R 7 are as defined in Table 2.
• Table Z represents Table 3 [when Z is 3], Table 4 [when Z is 4], Table 5 [when Z is 5], Table 6 [when Z is 6], Table 7 [when Z is 7], Table 8 [when Z is 8], Table 9 [when Z is 9], Table 10 [when Z is 10], Table 11 [when Z is 11], Table 12 [when Z is 12], Table 13 [when Z is 13], Table 14 [when Z is 14], Table 15 [when Z is 15], Table 16 [when Z is 16], Table 17 [when Z is 17], Table 18 [when Z is 18], Table 19 [when Z is 19], Table 20 [when Z is 20], Table 21 [when Z is 21], Table 22 [when Z is 22], Table 23 [when Z is 23], Table 24 [when Z is 24], Table 25 [when Z is 25], Table 26 [when Z is 26], Table 27 [when Z is 27], Table 28 [when Z is 28] and represents Table 29 [when Z is 29].
• X is either a single bond (—) or a double bond ( ⁇ ).
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 3.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 4.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 5.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 6.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 7.
• Table 8 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 8.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 9.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 10.
• Table 11 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 11.
• Table 12 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 12.
• Table 13 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 13.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 14.
• Table 15 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 15.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 16.
• Table 17 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 17.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 18.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 19.
• Table 20 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 20.
• Table 21 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 21.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 22.
• Table 23 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 23.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 24.
• Table 25 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 25.
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 26.
• Table 27 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 27.
• Table 28 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 28.
• Table 29 provides 235 compounds of formula (I) where Het is
• R 2 and R 3 are both hydrogen; and X, Y, R 1 , R 4 , R 5 , R 6 and R 7 are as defined in Table 29.
• Table 30 shows selected melting point and selected NMR data, all with CDCl 3 as the solvent (unless otherwise stated; if a mixture of solvents is present, this is indicated as, for example, [CDCl 3 /d 6 -DMSO]), (no attempt is made to list all characterising data in all cases) for compounds of Tables 1 to 29.
• syn:anti 86:14 6.91 (t, 1H), 6.65 (d, 1H), 6.49 (d, 1H), 3.5 (br, 2H), 3.20 (br, 1H), 3.15 (br, 1H), 1.92 (m, 2H), 1.54 (d, 1H), 1.19 (m, 2H), 1.03 (m, 1H), 0.81 (d, 6H).
• syn:anti 35:65 6.94-6.87 (m, 1H), 6.65 (m, 1H), 6.52 and 6.46 (d, 1H), 3.52 (br, 2H), 3.21, 3.16 and 3.14 (three m, 2H), 1.96-1.84 (m, 2H), 1.55 and 1.49 (two d, 1H), 1.43 and 1.03 (m, 1H), 1.22-1.12 (m, 2H), 0.92 and 0.82 (two m, 6H).
• syn:anti 82:18 6.92 (t, 1H), 6.64 (d, 1H), 6.50 (t, 1H), 3.53 (br, 2H), 3.08 (m, 1H), 3.03 (m, 1H), 2.02 (t, 1H), 1.90 (m, 2H), 1.46 (m, 1H), 1.16 (m, 2H), 0.92 (m, 2H), 0.81 (d, 6H).
• syn:anti 46:54 6.91 and 6.89 (two t, 1H), 6.63 (d, 1H), 6.48 and 6.46 (two d, 1H), 3.52 (br, 2H), 3.20, 3.16 and 3.13 (three, m, 2H), 1.93-1.86 (m, 2H), 1.78 and 1.72 (two d, 1H), 1.45 (m, 1H), 1.37-1.11 (m, 6H), 0.85 and 0.76 (two m, 6H).
• syn:anti 84:16 6.90 (t, 1H), 6.64 (d, 1H), 6.48 (d, 1H), 3.51 (br, 2H), 3.19 (br s, 1H), 3.13 (br s, 1H), 2.08 (t, 1H), 1.94 (m, 2H), 1.20 (m, 2H), 0.97 (m, 1H), 0.90 (m, 1H), 0.57 (1H), 0.35 (m, 2H), 0.13 (m, 2H).
• syn:anti 74:26 6.91 (t, 1H), 6.64 (d, 1H), 6.49 (d, 1H), 3.52 (br, 2H), 3.12 (br s, 1H), 3.08 (br s, 1H), 1.91 (m, 2H), 1.8-1.0 (m, 12H).
• syn:anti 74:26 7.28 (m, 2H), 7.17 (m, 1H), 7.04 (d, 2H), 6.99 (t, 1H), 6.72 (d, 1H), 6.57 (d, 1H), 3.6 (br, 2H), 3.06 (m, 2H), 2.35 (m, 2H), 2.20 (m, 1H), 1.89 (m, 2H), 1.20 (m, 2H).
• 3.172 amorphous solid syn-anti mixture 8.00 (s, 1H), 7.72 (br, 1H), 7.58 & 7..31 (d, 1H), 7.38 & 7.36 (br s, 1H), 7.16 (t, 1H), 7.11 & 7.09 (d, 1H), 7.01 (br s, 1H), 5.61 & 5.53 (br s, 1H), 5.19 & 5.09 (br s, 1H), 3.71 (s, 3H), 2.11 (m, 2H), 1.75-1.61 (m, 1H), 1.50-1.39 (m, 1H).
• syn:anti 90:10 7.91 (d, 1H), 7.72 (br, 1H), 7.38 (br s, 1H), 7.10 (t, 1H), 7.00 (br s, 1H), 6.97 (d, 1H), 3.72 (s, 3H), 3.32 (m, 1H), 3.22 (m, 1H), 1.95 (m, 2H), 1.58 (d, 1H), 1.20 (m, 2H), 0.90 (m, 1H), 0.81 (m, 6H).
• syn:anti 34:66 7.91 and 7.85 (two d, 1H), 7.72 (br, 1H), 7.37 (m, 1H), 7.12-7.05 (m, 1H), 6.99 (m, 1H), 6.98-6.94 (m, 1H), 3.71 (s, 3H), 3.32, 3.25. 3.22 and 3.19 (four m, 2H), 1.96-1.88 (m, 2H), 1.58 and 1.51 (two d, 1H), 1.44 and 0.98 (two m, 1H), 1.26-1.12 (m, 2H). 0.91 and 0.81 (two m, 6H).
• syn:anti 85:15 7.92 (d, 1H), 7.70 (br, 1H), 7.38 (br s, 1H), 7.11 (t, 1H), 6.99 (br s, 1H), 6.96 (d, 1H), 3.71 (s, 1H), 3.19 (m, 1H), 3.10 (m, 1H), 2.06 (t, 1H), 1.97 (m, 2H), 1.44 (m, 1H), 1.27-1.11 (m, 2H), 0.90 (m, 2H), 0.79 (d, 6H).
• syn:anti 95:05 7.90 (d, 1H), 7.71br, 1H), 7.38 (br s, 1H), 7.10 (t, 1H), 6.99 (br s, 1H), 6.96 (d, 1H), 3.71 (s, 3H), 3.31 (m, 1H), 3.18 (m, 1H), 2.12 (t, 1H), 1.98 (m, 2H), 1.28-1.14 (m, 3H), 1.0-0.78 (m, 2H), 0.55 (m, 1H), 0.34 (m, 2H), 0.16 (m, 2H).
• syn:anti 92:08 7.96 (d, 1H), 7.70 (br, 1H), 7.37 (br s, 1H), 7.30-6.95 (m, 8H), 3.72 (s, 3H), 3.18 (m, 1H), 3.12 (m, 1H), 2.37-2.07 (m, 3H), 1.93 (m, 2H), 1.25 (m, 2H).
• 14.162 142-147 8.09 (s, 1H), 7.74 (br, 1H), 7.63 (d, 1H), 7.19 (t, 1H), 7.08 (d, 1H), 4.40 (br s, 1H), 4.31 (br s, 1H), 4.00 (s, 3H), 2.26 (br, 2H), 2.15 (br, 2H), 1.38 (t, 1H), 1.26 (t, 1H), 1.05 (t, 3H).
• 14.168 amorphous solid 8.04 (s, 1H), 7.72 (br, 1H), 7.60 (d, 1H), 7.16 (t, 1H), 7.08 (d, 1H), 5.15 (br, 1H), 5.12 (br, 1H), 3.99 (s, 3H), 2.13 (m, 2H), 1.49 (m, 1H), 1.38 (s, 9H), 1.32 (m, 1H).
• syn:anti 90:10 8.06 (s, 1H), 7.84 (d, 1H), 7.70 (br, 1H), 7.12 (t, 1H), 7.01 (d, 1H), 3.99 (s, 3H), 3.29 (m, 1H), 3.23 (m, 1H), 1.96 (m, 2H), 1.60 (d, 1H), 1.20 (m, 2H), 0.96 (m, 1H), 0.80 (m, 6H).
• syn:anti 85:15 8.05 (br s, 1H), 7.84 (d, 1H), 7.68 (br, 1H), 7.12 (t, 1H), 7.00 (d, 1H), 3.99 (s, 3H), 3.16 (m, 1H), 3.12 (m, 1H), 2.10 (t, 1H), 1.97 (m, 2H), 1.44 (m, 1H), 1.22 (m, 2H), 0.91 (m, 2H), 0.80 (d, 6H).
• syn:anti 48:52 8.05 (br, 1H), 7.84 and 7.78 (two d, 1H), 7.69 (br, 1H), 7.14-7.08 (m, 1H), 6.99 (m, 1H), 3.99 (s, 3H), 3.29, 3.24 and 3.20 (three m, 2H), 1.95 (m, 2H), 1.83 and 1.74 (two d, 1H), 1.44 (m, 1H), 1.35-1.11 (m, 6H), 0.85 and 0.74 (two t, 6H).
• syn:anti 74:26 8.05 (s, 1H), 7.85 (d, 1H), 7.69 (br, 1H), 7.12 (t, 1H), 7.00 (d, 1H), 3.99 (s, 3H), 3.21 (m, 1H), 3.16 (m, 1H), 1.96 (m, 2H), 1.80-0.0.9 (m, 12H).
• 14.231 amorphous 8.05 (br s, 1H), 7.73 (d, overlapped by br, 2H), 7.09 (t, 1H), 7.01 (d, 1H), 3.99 (s, 3H), 3.82 (m, 1H), 3.79 (m, 1H), 2.1-1.95 (m, 4H), 1.92 (m, 2H), 1.38-1.23 (m, 2H), 0.93 (m, 6H).
• syn:anti 90:10 8.53 (m, 1H), 8.28 (d, 1H), 8.17 (br, 1H), 7.82 (d, 1H), 7.42 (d, 1H), 7.15 (t, 1H), 7.05 (d, 1H), 3.37 (m, 1H), 3.26 (m, 1H), 1.98 (m, 2H), 1.62 (d, 1H), 1.24 (m, 2H), 0.97 (m, 1H), 0.82 (d, 6H).
• 29.231 amorphous 8.53 (m, 1H), 8.26 (d, 1H), 8.16 (br, 1H), 7.73 (d, 1H), 7.43 (m, 1H), 7.13 (t, 1H), 7.05 (d, 1H), 3.91 (m, 1H), 3.81 (m, 1H), 2.1-1.89 (m, 6H), 1.40-1.23 (m, 2H), 0.93 (m, 6H).
• the compounds according to formula (I) may be prepared according to the following reaction schemes.
• a compound of formula (I) [where R 1 is hydrogen; and Het, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , X and Y are as defined above for a compound of formula (I)] may be synthesized by reacting a compound of (II) [where Het is as defined above for a compound of formula (I) and R′ is C 1-5 alkyl] with an aniline of formula (III) [where R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , X and Y are as defined above for a compound of formula (I)] in the presence of NaN(TMS) 2 at ⁇ 10° C. to ambient temperature, preferably in dry THF, as described by J. Wang et al. Synlett, 2001, 1485.
• a compound of formula (I) [where R 1 is hydrogen; and Het, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , X and Y are as defined above for a compound of formula (I)] may be prepared by reacting a compound of formula (II′) [where Het is as defined above for a compound of formula (I)] with an aniline of formula (III) [where R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , X and Y are as defined above for a compound of formula (I)] in the presence of an activating agent [such as BOP-Cl] and two equivalents of a base [such as triethylamine] or by reacting a compound of formula (II′′) [where Het is as defined above for a compound of formula (I); and Q is Cl, F or Br] which is obtained from a compound of formula (II′) by treatment with a halogenating agent such as
• a compound of formula (I) [where R 1 is hydrogen; and Het, R 2 to R 7 , X and Y are as defined for a compound of formula (I)] is reacted with a species Z-R 1 [where R 1 is as defined for formula (I), except that it is not hydrogen; and Z is preferably Cl, Br or I; or Z is such that Z-R 1 is an anhydride, that is, when R 1 is COR*, Z is OCOR*] in the presence of a base [for example NaH, NEt 3 , NaHCO 3 or K 2 CO 3 ] in an appropriate solvent [such as ethyl acetate] or in a biphasic mixture [such as dichloromethane/water mixture], at ⁇ 10 to 30° C.
• a base for example NaH, NEt 3 , NaHCO 3 or K 2 CO 3
• an appropriate solvent such as ethyl acetate
• a biphasic mixture such as dichloromethane/water mixture
• Heterocyclic acids and esters that is, compounds of formula (II′) or (II)] are generally known from the literature or may be synthesized according to known methods.
• Ortho-substituted aminobenzonorbonenes may be accomplished through Diels-Alder addition of an in situ generated benzyne [for example starting from a 6-nitroanthranilic acid of formula (A), as described by L. Paquette et al, J. Amer. Chem. Soc. 99, 3734 (1977) or from other suitable precursers (see H. Pellissier et al. Tetrahedron, 59, 701 (2003)] to a 5-7 membered cyclic 1,4-diene to give a nitro-benzonorbornadiene of formula (B) according to or by analogy to L. Paquette et al, J.
• Suitable aprotic solvents for this step include ethyl acetate, dichloromethane, acetone, THF and dimethoxyethane. Reaction temperatures range from room temperature to 100° C., preferably 40-80° C.
• a compound of formula (C) may also be obtained from a compound of formula (B) by catalytic hydrogen reduction with a modified 5% Pt/C catalyst at elevated pressure ( ⁇ 10 bar) and elevated temperature ( ⁇ 100° C.) in toluene-water.
• Catalytic reduction under standard conditions for example 5% Pd/C or 5% Ra/Ni or 5% Rh/C
• a solvent such as methanol, ethanol, THF or ethyl acetate
• Preferred reaction conditions are ambient temperature and normal pressure.
• Novel starting materials of formulae (C) or (D) may be synthesized by analogy to scheme 4 or according to the literature cited above.
• novel compounds of formula (I) have, for practical purposes, a very advantageous spectrum of activities for protecting plants against diseases that are caused by fungi as well as by bacteria and viruses.
• the compounds of formula (I) can be used in the agricultural sector and related fields of use as active ingredients for controlling plant pests.
• the novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and are used for protecting numerous cultivated plants.
• the compounds of formula I can be used to inhibit or destroy the pests that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later e.g. from phytopathogenic microorganisms.
• compounds of formula (I) as dressing agents for the treatment of plant propagation material, in particular of seeds (fruit, tubers, grains) and plant cuttings (e.g. rice), for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil.
• the compounds according to present invention may be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene management, etc.
• the compounds of formula (I) are, for example, effective against the phytopathogenic fungi of the following classes: Fungi imperfecti (e.g. Botrytis, Pyricularia, Helminthosporium, Fusarium, Septoria, Cercospora and Alternaria ) and Basidiomycetes (e.g. Rhizoctonia, Hemileia, Puccinia ). Additionally, they are also effective against the Ascomycetes classes (e.g. Venturia and Erysiphe, Podosphaera, Monilinia, Uncinula ) and of the Oomycetes classes (e.g. Phytophthora, Pythium, Plasmopara ).
• Fungi imperfecti e.g. Botrytis, Pyricularia, Helminthosporium, Fusarium, Septoria, Cercospora and Alternaria
• Basidiomycetes e.g. Rhizoctonia, Hemileia, Puccinia
• novel compounds of formula I are effective against phytopathogenic bacteria and viruses (e.g. against Xanthomonas spp, Pseudomonas spp, Erwinia amylovora as well as against the tobacco mosaic virus).
• target crops to be protected typically comprise the following species of plants: cereal (wheat, barley, rye, oat, rice, maize, sorghum and related species); beet (sugar beet and fodder beet); pomes, drupes and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries); leguminous plants (beans, lentils, peas, soybeans); oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans, groundnuts); cucumber plants (pumpkins, cucumbers, melons); fibre plants (cotton, flax, hemp, jute); citrus fruit (oranges, lemons, grapefruit, mandarins); vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, paprika); lauraceae (avocado, cinnamomum, camphor) or plants such as tobacco
• the compounds of formula (I) are used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they are conveniently formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances.
• the methods of application such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances.
• the compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.
• Suitable carriers and adjuvants can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers. Such carriers are for example described in WO97/33890.
• the compounds of formula (I) are normally used in the form of compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds.
• further compounds can be e.g. fertilizers or micronutrient donors or other preparations which influence the growth of plants. They can also be selective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation.
• the compounds of formula (I) can be mixed with other fungicides, resulting in some cases in unexpected synergistic activities.
• Mixing components which are particularly preferred are azoles, such as azaconazole, BAY 14120, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, pefurazoate, penconazole, pyrifenox, prochloraz, propiconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole, triticonazole; pyrimidinyl carbino
• a preferred method of applying a compound of formula (I), or an agrochemical composition which contains at least one of said compounds, is foliar application.
• the frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen.
• the compounds of formula I can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid formulation, or by applying the compounds in solid form to the soil, for example in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field.
• the compounds of formula I may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation.
• a formulation that is, a composition containing the compound of formula (I)] and, if desired, a solid or liquid adjuvant, is prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
• extenders for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
• the agrochemical formulations will usually contain from 0.1 to 99% by weight, preferably from 0.1 to 95% by weight, of the compound of formula I, 99.9 to 1% by weight, preferably 99.8 to 5% by weight, of a solid or liquid adjuvant, and from 0 to 25% by weight, preferably from 0.1 to 25% by weight, of a surfactant.
• Advantageous rates of application are normally from 5 g to 2 kg of active ingredient (a.i.) per hectare (ha), preferably from 10 g to 1 kg a.i./ha, most preferably from 20 g to 600 g a.i./ha.
• convenient dosages are from 10 mg to 1 g of active substance per kg of seeds.
• Botrytis cinerea /Grape Botrytis on Grapes
• Botrytis cinerea /Tomato Botrytis on Tomatoes
• the formulated test compound (0.002% active ingredient) is applied into a pouch which was previously equipped with a filter paper. After the application barley seeds (cv. Express) are sown into the upper fault of the filter paper. The prepared pouches are then incubated at 23° C./18° C. (day/night) and 80% r.h. One week after sowing barley plants were inoculated by shaking powdery mildew infected plants above the test plants. After an incubation period of 6 days the disease incidence was assessed. The efficacy of each test compound is used as an indicator for systemic activity.
• a conidia suspension of F. culmorum (7 ⁇ 10 5 conidia/ml) is mixed with the formulated test compound (0.002% active ingredient).
• the mixture is applied into a pouch which was previously equipped with a filter paper.
• wheat seeds cv. Orestis
• the prepared pouches are then incubated for 11 days at ca. 10-18° C. and 100% r.h. with a daily light period of 14 hours.
• the evaluation is made by assessing the degree of disease occurrence in the form of brown lesions on the roots.
• a defined amount of mycelium of G. graminis is mixed with water.
• the formulated test compound (0.002% active ingredient) is added to the mycelium suspension.
• the mixture is applied into a pouch which was previously equipped with a filter paper. After the application wheat seeds (cv. Orestis) are sown into the upper fault of the filter paper.
• the prepared pouches are then incubated for 14 days at 18° C./16° C. (day/night) and 80% r.h. with a daily light period of 14 hours. The evaluation is made by assessing the degree of root browning.
• Formulated test compound (0.002% active ingredient) is applied into a pouch which was previously equipped with a filter paper. After the application wheat seeds (cv. Arina) are sown into the upper fault of the filter paper. The prepared pouches are then incubated at 23° C./18° C. (day/night) and 80% r.h. One week after sowing, the wheat plants were inoculated by spraying a spore suspension (1 ⁇ 10 5 uredospores/ml) on the test plants. After an incubation period of 1 day at 23° C. and 95% r.h. the plants were kept for 9 days at 20° C./18° C. (day/night) and 80% r.h. The disease incidence was assessed 10 days after inoculation. The efficacy of each test compound is used as an indicator for systemic activity.
• a defined amount of mycelium of R. solani is mixed with water.
• the formulated test compound (0.002% active ingredient) is added to the mycelium suspension.
• the mixture is applied into a pouch which was previously equipped with a filter paper.
• rice seeds cv. Koshihikari
• rice seeds are sown into the upper fault of the filter paper.
• the prepared pouches are then incubated for 10 days at 23° C./21° C. (day/night) and 100% r.h. with a daily light period of 14 hours.
• the evaluation is made by assessing the degree of disease occurrence in the form of brown lesions on the roots.
• the formulated test compound (0.002% active ingredient) was applied into a pouch which was previously equipped with a filter paper. After the application, wheat seeds (cv. Arina) were sown into the upper fault of the filter paper. The prepared pouches were then incubated at 23° C./18° C. (day/night) and 80% r.h. One week after sowing, the wheat plants were inoculated by spraying a spore suspension (5 ⁇ 10 5 conidia/ml) on the test plants. After an incubation period of 1 day at 23° C. and 95% r.h. the plants were kept for 9 days at 20° C./18° C. (day/night) and 80% r.h. The disease incidence was assessed 8 days after inoculation. The efficacy of each test compound is used as an indicator for systemic activity.
• Compounds 14.202 or 14.210 each show good activity in this test ( ⁇ 20% disease incidence).

Landscapes

• Organic Chemistry (AREA)
• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Health & Medical Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Plant Pathology (AREA)
• Pest Control & Pesticides (AREA)
• Engineering & Computer Science (AREA)
• Dentistry (AREA)
• Agronomy & Crop Science (AREA)
• Wood Science & Technology (AREA)
• Zoology (AREA)
• Environmental Sciences (AREA)
• Oncology (AREA)
• Animal Behavior & Ethology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Pharmacology & Pharmacy (AREA)
• Communicable Diseases (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Plural Heterocyclic Compounds (AREA)
• Agricultural Chemicals And Associated Chemicals (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
• Pyrrole Compounds (AREA)

Applications Claiming Priority (3)

Related Parent Applications (1)

Related Child Applications (1)

Publications (2)

Family

ID=9946176

Family Applications (2)

Family Applications After (1)

Country Status (39)

Cited By (5)

Families Citing this family (108)

Citations (23)

Family Cites Families (9)

• 2002
  • 2002-10-18 GB GBGB0224316.0A patent/GB0224316D0/en not_active Ceased
• 2003
  • 2003-10-14 CN CNB2003801016261A patent/CN100448876C/zh not_active Expired - Lifetime
  • 2003-10-14 SI SI200331806T patent/SI1556385T1/sl unknown
  • 2003-10-14 KR KR1020087004758A patent/KR100872010B1/ko active IP Right Grant
  • 2003-10-14 EP EP03772217A patent/EP1556385B1/en not_active Expired - Lifetime
  • 2003-10-14 AU AU2003280376A patent/AU2003280376B2/en not_active Expired
  • 2003-10-14 DK DK03772217.0T patent/DK1556385T3/da active
  • 2003-10-14 WO PCT/EP2003/011388 patent/WO2004035589A1/en active Application Filing
  • 2003-10-14 GE GEAP200310254A patent/GEP20115347B/en unknown
  • 2003-10-14 KR KR1020057006640A patent/KR100858013B1/ko active Protection Beyond IP Right Term
  • 2003-10-14 ME MEP-316/08A patent/MEP31608A/xx unknown
  • 2003-10-14 RS YU20050297A patent/RS51937B/sr unknown
  • 2003-10-14 ME MEP-2008-316A patent/ME00223B/me unknown
  • 2003-10-14 GE GEAP20038803A patent/GEP20084500B/en unknown
  • 2003-10-14 EA EA200800883A patent/EA015708B1/ru not_active IP Right Cessation
  • 2003-10-14 ES ES03772217T patent/ES2342714T3/es not_active Expired - Lifetime
  • 2003-10-14 NZ NZ539376A patent/NZ539376A/en not_active IP Right Cessation
  • 2003-10-14 US US10/530,737 patent/US7598395B2/en active Active
  • 2003-10-14 JP JP2004544232A patent/JP4607591B2/ja not_active Expired - Lifetime
  • 2003-10-14 PT PT03772217T patent/PT1556385E/pt unknown
  • 2003-10-14 BR BRPI0314875-0A patent/BR0314875B1/pt active IP Right Grant
  • 2003-10-14 PL PL376574A patent/PL221973B1/pl unknown
  • 2003-10-14 DE DE60331670T patent/DE60331670D1/de not_active Expired - Lifetime
  • 2003-10-14 MX MXPA05003899A patent/MXPA05003899A/es active IP Right Grant
  • 2003-10-14 UA UAA200504639A patent/UA81784C2/uk unknown
  • 2003-10-14 AT AT03772217T patent/ATE460418T1/de active
  • 2003-10-14 EA EA200500574A patent/EA010264B1/ru not_active IP Right Cessation
  • 2003-10-14 CA CA2498851A patent/CA2498851C/en not_active Expired - Lifetime
  • 2003-10-16 AR ARP030103781A patent/AR041649A1/es active IP Right Grant
  • 2003-10-17 TW TW092128889A patent/TWI319704B/zh active
• 2005
  • 2005-03-04 ZA ZA200501870A patent/ZA200501870B/en unknown
  • 2005-03-07 IL IL167290A patent/IL167290A/en active IP Right Grant
  • 2005-03-10 CR CR7727A patent/CR7727A/es unknown
  • 2005-03-15 EC EC2005005675A patent/ECSP055675A/es unknown
  • 2005-04-12 EG EGNA2005000128 patent/EG24050A/xx active
  • 2005-04-13 MA MA28216A patent/MA27405A1/fr unknown
  • 2005-04-18 TN TNP2005000112A patent/TNSN05112A1/fr unknown
  • 2005-05-04 NO NO20052201A patent/NO331404B1/no not_active IP Right Cessation
  • 2005-05-17 HR HRP20050441AA patent/HRP20050441B1/hr not_active IP Right Cessation
• 2006
  • 2006-04-11 HK HK06104366.2A patent/HK1082254A1/xx not_active IP Right Cessation
• 2008
  • 2008-03-20 IL IL190341A patent/IL190341A/en active IP Right Grant
• 2009
  • 2009-08-28 US US12/549,478 patent/US7994093B2/en not_active Expired - Lifetime
• 2010
  • 2010-06-09 CY CY20101100545T patent/CY1110077T1/el unknown
• 2013
  • 2013-06-20 BE BE2013C039C patent/BE2013C039I2/fr unknown
• 2018
  • 2018-06-05 FR FR18C1024C patent/FR18C1024I2/fr active Active

Patent Citations (24)

Non-Patent Citations (8)

Also Published As

Similar Documents

Legal Events